Physician profile
Gabriel Luis Pagani-Estevez
NPI 1508204637
$179,390.55
in general payments reported to CMS, 2019-2025
29 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,877 · 2020: $527 · 2021: $1,213 · 2022: $3,337 · 2023: $9,772 · 2024: $77K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $82K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Travel and Lodging: $24K · Food and Beverage: $13K · Education: $5,363 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $82,019.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41,920.00 |
| Travel and Lodging | $24,026.47 |
| Food and Beverage | $12,633.19 |
| Education | $5,362.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $46,716.58 | 2023-2025 | Evoke, Evoke Scs |
| Mml US, INC. | $43,322.47 | 2022-2025 | Reactiv8 |
| Medtronic, INC. | $27,234.56 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Spinal Simplicity, LLC | $20,699.40 | 2023-2025 | Ha Minuteman G3-R, Liberty Si |
| Convatec INC. | $16,490.85 | 2024-2025 | Aquacel Ag Surgical |
| Abbott Laboratories | $8,183.99 | 2019-2025 | Proclaim, Eterna |
| Painteq LLC | $4,116.18 | 2023-2025 | Painteq |
| Relievant Medsystems, INC. | $3,409.11 | 2021-2023 | Intracept |
| Medtronic USA, INC. | $3,166.28 | 2019 | |
| Bioventus LLC | $1,163.24 | 2022-2023 | Stimrouter Implantable Kit |
| Curonix LLC | $969.02 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertiflex, INC. | $932.87 | 2019 | |
| Nevro Corp. | $770.94 | 2019-2023 | Senza |
| Boston Scientific Corporation | $554.12 | 2019-2024 | Intracept, Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Spr Therapeutics, INC | $524.33 | 2019-2025 | Sprint Pns System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $331.81 | 2022-2024 | Mild Device Kit |
| Lilly USA, LLC | $207.99 | 2019 | |
| Vertos Medical, INC. | $155.32 | 2022-2023 | Mild Device Kit |
| Amgen INC. | $114.65 | 2019 | |
| Biotronik Nro, INC. | $65.39 | 2025 | Prospera |
| Pfizer INC. | $57.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.63 | 2019 | |
| Globus Medical, INC. | $43.56 | 2025 | Senza |
| Amneal Pharmaceuticals LLC | $25.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.16 | 2019 | |
| Nalu Medical, INC. | $20.87 | 2023 | Nalu Neurostimulation System |
| Acorda Therapeutics, INC | $16.95 | 2019 | |
| Allergan, INC. | $14.97 | 2019 | |
| Daiichi Sankyo INC. | $14.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Pagani-Estevez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.